In an effort to effectively address global health concerns, the WHO has announced the 13th General Programme of Work, a 5-year strategic plan spanning from 2019 to 2023.
Researchers found that drugs used to treat rheumatoid arthritis have been associated with varicella zoster activation.
Weight loss in patients who are overweight or obese may improve symptoms through pathologic mechanisms in addition to reduction of joint burden.
Given the substantial overlap with RA, emerging theories suggest that undifferentiated arthritis represents a unique window of opportunity to intervene in the pathology of RA before it becomes established.
Preliminary evidence has found an association between the cannabinoid system and other rheumatic conditions, but the studies have not provided conclusive results that could drive recommendations.
Obesity has a substantial effect on general health parameters, but its role in rheumatoid arthritis is much more complex.
Quality of life measurements capture unique information about systemic lupus erythematosus that are not included in disease activity or damage evaluations.
John M. Davis III, MD, MS, from the Mayo Clinic in Rochester, Minnesota, and Jennifer Gorman, MD, MPH, from The Polyclinic in Seattle, Washington, discuss the evolving collaborative care therapy model in RA.
Petros Efthimiou, MD, a rheumatologist at NYU Langone Health, discusses how clinicians should approach prescribing potentially teratogenic drugs in pregnancy.
Advances in the management of systemic lupus erythematosus have improved quality of life and outcomes for women who are considering pregnancy.
